SEC Comment Letter for Veradermics, (MANE) — Apr 7, 2026
Veradermics, Inc
Date: April 7, 2026 · CIK: 0001827635 · Accession: 0000000000-26-003484
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Veradermics, Incorporated Draft Registration Statement on Form S-1 Submitted April 6, 2026 CIK No. 0001827635 Dear Reid Waldman:
April 7, 2026
Reid Waldman Chief Executive Officer Veradermics, Incorporated 470 James St. New Haven, CT 06513
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Nicholas Roper
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 7, 2026 Reid Waldman Chief Executive Officer Veradermics, Incorporated 470 James St. New Haven, CT 06513 Re: Veradermics, Incorporated Draft Registration Statement on Form S-1 Submitted April 6, 2026 CIK No. 0001827635 Dear Reid Waldman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nicholas Roper </TEXT> </DOCUMENT>